Topic: How To Invest

Q: Can I get TSI’s take on Inari Medical as a stock to consider adding to my holdings? Thanks.

Article Excerpt

A: Inari Medical Inc., $57.16, symbol NARI on Nasdaq (Shares outstanding: 57.6 million; Market cap: $3.3 billion; www.inarimedical.com), is a medical device company whose products treat patients suffering from Chronic Venous Disease (phlebitis) and other related issues. Its two main products are ClotTrievers, which remove blood clots from blood vessels, and FlowTrievers, which treat pulmonary embolisms (when blood clots, often in the legs, break off and flow through the veins to cause a blockage). Inari first sold shares to the public and began trading on May 27, 2020, at $19 a share. The next day, the shares jumped to $42.91. They kept on rising to a peak, about a year later, of $130, and they have since headed steadily sideways to downwards. On November 1, 2023, Inari agreed to acquire LimFlow S.A., a privately owned French medical device company whose products treat chronic limb-threatening ischemia (CLTI). (That’s when blood flow in the limbs is severely restricted.) LimFlow devices work to deliver oxygenated…